Organisation paid for research Program year 2021 Source: CMS Open Payments

Aaim Care LLC

Neither a doctor nor a teaching hospital

Research payments

$15,246

14 payments

Through program year 2021, Aaim Care LLC is reported as receiving $15,246 in research payments, across 14 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$13,159	10
2019	Research	$2,087	4

Breakdown

Who paid Research payments · program years 2019–2021

Pfizer Inc. $10,297 6 payments
Takeda Pharmaceuticals U.S.A., Inc. $2,862 4 payments
Shire North American Group Inc $2,000 2 payments
BioCryst Pharmaceuticals, Inc. $87 2 payments

Studies the money was for Research payments · program years 2019–2021

A Phase 3 Multicenter Longterm Extension Study Investigating the Efficacy and Safety of Abrocitinib With Or Without Topical Medications Administered to Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis $10,297 6 payments
An Observational, Non-Interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (Empower Study) $2,862 4 payments
An Observational, Non-Interventional, Study of Patients With Hereditary Angioedema in the United States and Canada Empower Study $2,000 2 payments
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to evaluate the efficacy and safety of two dose levels of BCX7353 as an oral treatment for the prevention of attacks in subjects with Hereditary Angioedema $87 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.